ABUS Dec 2024 5.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:57PM EDT. Market open.
| Previous close | 0.1500 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 5.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.1000 - 0.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- GuruFocus.com
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Insights into Arbutus Biopharma Corp's Q1 performance, including financial updates and progress in clinical trials.
- GuruFocus.com
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
Insights into Arbutus Biopharma's First Quarter Performance and Strategic Updates
ZacksArbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
Arbutus (ABUS) delivered earnings and revenue surprises of 0% and 28.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.